Dave360Test03

mainProject/mainProject.xml aka Dave Test 3

This website contains scientific and medical publications for purposes of scientific information exchange. These publications may discuss uses that have not been approved or cleared by the US Food and Drug Administration. The publications linked to on this site are all third-party peer-reviewed publications or documents from scientific meetings which disclose any contribution of devices and/or technical support by Bunnell, in accordance with the publisher’s conflict-of-interest disclosure policy. The LifePulse HFV is indicated for use in ventilating critically ill infants with pulmonary interstitial emphysema (PIE). Infants studied ranged in birth weight from 750 to 3,529 grams and in gestational age from 24 to 41 weeks. The LifePulse High-Frequency Ventilator is also indicated for use in ventilating critically ill infants with respiratory distress syndrome (RDS) complicated by pulmonary air leaks who are, in the opinion of their physicians, failing on conventional ventilation. The infants studied ranged in birth weight from 600 to 3,660 grams and in gestational age from 24 to 38 weeks.